Fair Value Measurements and Investments - Schedule of Change in Valuation of Securities (Detail) - Bone Biologics Inc [Member] - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2022
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Equity securities beginning balance	$ 0	$ 309
Fair value adjustments and impairments recognized in other expense, net	0	(183)
Proceeds from the disposition of equity securities	0	$ (126)
Equity securities ending balance	$ 0